DeferasiroxHyperammonaemia and fanconi syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2034卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70497-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：124 / 124

相关论文

共 50 条

[31] Abacavir/stavudineMetabolic acidosis and Fanconi syndrome: case report
Reactions Weekly, 2013, 1441 (1) : 5 - 5
[32] Adefovir/teriparatideDevelopment and worsening of Fanconi syndrome: case report
Reactions Weekly, 2020, 1793 (1) : 24 - 24
[33] Zoledronic acidTubulointerstitial nephritis with Fanconi syndrome: case report
Reactions Weekly, 2013, 1438 (1) : 30 - 30
[34] TenofovirRenal tubular acidosis and Fanconi syndrome: case report
Reactions Weekly, 2018, 1695 (1) : 339 - 339
[35] IfosfamidePartial fanconi syndrome and intestinal dysmotility: case report
Reactions Weekly, 2025, 2040 (1) : 444 - 444
[36] AdefovirHypophosphataemic osteomalacia caused by fanconi syndrome: case report
Reactions Weekly, 2017, 1673 (1) : 29 - 29
[37] Fainting Fanconi syndrome clarified by proxy: a case report
Walsh, Stephen Benedict
Unwin, Robert
Kleta, Robert
Van't Hoff, William
Bass, Paul
Hussain, Khalid
Ellard, Sian
Bockenhauer, Detlef
BMC NEPHROLOGY, 2017, 18
[38] DeferasiroxHyperammonaemia, metabolic encephalopathy and acute kidney injury: case report
Reactions Weekly, 2019, 1752 (1) : 126 - 126
[39] Adefovir dipivoxilHypophosphataemic osteomalacia associated with Fanconi syndrome: case report
Reactions Weekly, 2019, 1751 (1) : 14 - 14
[40] CisplatinAcquired fanconi syndrome and renal tubular acidosis: case report
Reactions Weekly, 2020, 1798 (1) : 82 - 82

← 1 2 3 4 5 →